[HTML][HTML] Emerging concepts and technologies in vaccine development

M Brisse, SM Vrba, N Kirk, Y Liang, H Ly - Frontiers in immunology, 2020 - frontiersin.org
Despite the success of vaccination to greatly mitigate or eliminate threat of diseases caused
by pathogens, there are still known diseases and emerging pathogens for which the …

Virology, pathogenesis, diagnosis and in-line treatment of COVID-19

PK Samudrala, P Kumar, K Choudhary… - European journal of …, 2020 - Elsevier
Abstract SARS-CoV-2, a newly emerged pathogen in December 2019, marked as one of the
highly pathogenic Coronavirus, and altogether this is the third coronavirus attack that …

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity

V Schijns, EC Lavelle - European journal of immunology, 2020 - Wiley Online Library
The recent outbreak of coronavirus disease 2019 (COVID‐19), triggered by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses an enormous threat to global …

Berantas Hoax Seputar Vaksin Covid 19 Melalui Kegiatan Edukasi dan Sosialisasi Vaksin Covid 19

A Nurdiana, R Marlina… - ABDIMAS: Jurnal …, 2021 - journal.umtas.ac.id
Ditengah merebaknya rencana pemerintah untuk pemberian vaksinasi Covid-19 (Sinovac)
secara massal, berbagai hoax bermunculan di dalam media online, bahkan seringkali …

Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA

G Milano, J Gal, A Creisson, E Chamorey - Future Virology, 2022 - Future Medicine
While tolerance to COVID-19 vaccination is considered satisfactory, a phenomenon of
myocarditis, although rare, is becoming a safety concern in mRNA COVID-19 vaccination …

Analyzing the systems biology effects of COVID-19 mRNA vaccines to assess their safety and putative side effects

R Hajjo, DA Sabbah, A Tropsha - Pathogens, 2022 - mdpi.com
COVID-19 vaccines have been instrumental tools in reducing the impact of SARS-CoV-2
infections around the world by preventing 80% to 90% of hospitalizations and deaths from …

Protecting the herd: why pharmacists matter in mass vaccination

L Lee, GM Peterson, M Naunton, S Jackson, M Bushell - Pharmacy, 2020 - mdpi.com
Background: The COVID-19 pandemic is ongoing. The unprecedented challenges
worldwide implore the urgent development of a safe and effective COVID-19 vaccine …

COVID-19: myths and reality

LV Kordyukova, AV Shanko - Biochemistry (Moscow), 2021 - Springer
COVID‑19, a new human respiratory disease that has killed nearly 3 million people in a year
since the start of the pandemic, is a global public health challenge. Its infectious agent …

Smart and sustainable nanotechnological solutions in a battle against COVID-19 and beyond: a critical review

AM Jastrzebska, AS Vasilchenko - ACS Sustainable Chemistry & …, 2021 - ACS Publications
The variety of available biocidal features make nanomaterials promising for fighting
infections. To effectively battle COVID-19, categorized as a pandemic by the World Health …

COVID‐19 vaccines and nanomedicine

RS Shapiro - International journal of dermatology, 2021 - Wiley Online Library
Background The COVID‐19 virus‐induced pandemic has been the deadliest pandemic to
have occurred in two generations, besides HIV/AIDS. Epidemiologists predicted that the …